Industry Growth Insights published a new data on “Microneedle Flu Vaccine Market”. The research report is titled “Microneedle Flu Vaccine Market research by Types (Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle), By Applications (Influenza A, Influenza B), By Players/Companies Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals, Microdermics and OraSure Technologies, Sanofi”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microneedle Flu Vaccine Market Research Report
By Type
Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle
By Application
Influenza A, Influenza B
By Companies
Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals, Microdermics and OraSure Technologies, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Microneedle Flu Vaccine Market Report Segments:
The global Microneedle Flu Vaccine market is segmented on the basis of:
Types
Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Influenza A, Influenza B
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- GC Pharma
- Debiotech
- NanoPass Technologies
- Corium International
- Becton Dickinson and Company
- FluGen
- CosMED Pharmaceuticals
- Microdermics and OraSure Technologies
- Sanofi
Highlights of The Microneedle Flu Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solid Microneedle
- Hollow Microneedle
- Coated Microneedle
- Dissolving Microneedle
- By Application:
- Influenza A
- Influenza B
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microneedle Flu Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microneedle flu vaccine is a new type of vaccine that uses tiny needles to inject the vaccine into the skin. This type of vaccine is easier and faster to use than traditional vaccines, which can take up to two weeks to develop immunity. Microneedle flu vaccines are also more effective because they target the virus directly, rather than using a dead or weakened virus as in traditional vaccines.
Some of the key players operating in the microneedle flu vaccine market are Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals, Microdermics and OraSure Technologies, Sanofi.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microneedle Flu Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microneedle Flu Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microneedle Flu Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microneedle Flu Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microneedle Flu Vaccine Market Size & Forecast, 2018-2028
4.5.1 Microneedle Flu Vaccine Market Size and Y-o-Y Growth
4.5.2 Microneedle Flu Vaccine Market Absolute $ Opportunity
Chapter 5 Global Microneedle Flu Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Microneedle Flu Vaccine Market Size Forecast by Type
5.2.1 Solid Microneedle
5.2.2 Hollow Microneedle
5.2.3 Coated Microneedle
5.2.4 Dissolving Microneedle
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Microneedle Flu Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Microneedle Flu Vaccine Market Size Forecast by Applications
6.2.1 Influenza A
6.2.2 Influenza B
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microneedle Flu Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microneedle Flu Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Microneedle Flu Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Microneedle Flu Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Microneedle Flu Vaccine Market Size Forecast by Type
9.6.1 Solid Microneedle
9.6.2 Hollow Microneedle
9.6.3 Coated Microneedle
9.6.4 Dissolving Microneedle
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Microneedle Flu Vaccine Market Size Forecast by Applications
9.10.1 Influenza A
9.10.2 Influenza B
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Microneedle Flu Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Microneedle Flu Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Microneedle Flu Vaccine Market Size Forecast by Type
10.6.1 Solid Microneedle
10.6.2 Hollow Microneedle
10.6.3 Coated Microneedle
10.6.4 Dissolving Microneedle
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Microneedle Flu Vaccine Market Size Forecast by Applications
10.10.1 Influenza A
10.10.2 Influenza B
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Microneedle Flu Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Type
11.6.1 Solid Microneedle
11.6.2 Hollow Microneedle
11.6.3 Coated Microneedle
11.6.4 Dissolving Microneedle
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Applications
11.10.1 Influenza A
11.10.2 Influenza B
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Microneedle Flu Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Microneedle Flu Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Microneedle Flu Vaccine Market Size Forecast by Type
12.6.1 Solid Microneedle
12.6.2 Hollow Microneedle
12.6.3 Coated Microneedle
12.6.4 Dissolving Microneedle
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Microneedle Flu Vaccine Market Size Forecast by Applications
12.10.1 Influenza A
12.10.2 Influenza B
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Microneedle Flu Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Microneedle Flu Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Microneedle Flu Vaccine Market Size Forecast by Type
13.6.1 Solid Microneedle
13.6.2 Hollow Microneedle
13.6.3 Coated Microneedle
13.6.4 Dissolving Microneedle
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Microneedle Flu Vaccine Market Size Forecast by Applications
13.10.1 Influenza A
13.10.2 Influenza B
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microneedle Flu Vaccine Market: Competitive Dashboard
14.2 Global Microneedle Flu Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 GC Pharma
14.3.3 Debiotech
14.3.4 NanoPass Technologies
14.3.5 Corium International
14.3.6 Becton Dickinson and Company
14.3.7 FluGen
14.3.8 CosMED Pharmaceuticals
14.3.9 Microdermics and OraSure Technologies
14.3.10 Sanofi
